Are you Dr. Acuna-Villaorduna?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
725 Albany St
Boston, MA 02118Phone+1 617-414-3611
Summary
- Dr. Carlos Acuna-Villaorduna, MD is an infectious disease specialist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Pennsylvania, and District of Columbia. He is affiliated with Boston Medical Center and Lemuel Shattuck Hospital.
Education & Training
- Cayetano Heredia UniversityClass of 2003
Certifications & Licensure
- MA State Medical License 2016 - 2026
- PA State Medical License 2010 - 2014
- DC State Medical License 2006 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 65 citationsInfant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analy...Leonardo Martinez, Olivia Cords, Qiao Liu, Carlos Acuna-Villaorduna, Maryline Bonnet
The Lancet. Global Health. 2022-09-01 - 37 citationsCost-Effectiveness Analysis of Introduction of Rapid, Alternative Methods to Identify Multidrug-Resistant Tuberculosis in Middle-Income CountriesCarlos Acuna-Villaorduna, Anna Vassall, German Henostroza, Carlos Seas, Humberto Guerra
Clinical Infectious Diseases. 2008-08-15 - 14 citationsNutritional Supplementation Would Be Cost-Effective for Reducing Tuberculosis Incidence and Mortality in India: The Ration Optimization to Impede Tuberculosis (ROTI-TB...Pranay Sinha, Subitha L Lakshminarayanan, Chelsie Cintron, Prakash Babu Narasimhan, Lindsey M Locks
Clinical Infectious Diseases. 2022-09-10
Press Mentions
- Study Demonstrates Efficacy of New Short-Term Resistant TB TreatmentAugust 1st, 2023